Skip to main content

Annals of Hematology

Ausgabe 6/2024

Inhalt (38 Artikel)

Review Article

CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia

Abdulfatah M. Alayoubi, Zakaria Y. Khawaji, Mohammed A. Mohammed, François E. Mercier

Review Article

Therapeutic progress in relapsed/refractory multiple myeloma

Qi Chen, Min Zhang, Shan Zheng, Yuxin Tong, Yamin Tan

Review Article

Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia

Xiangyu Wang, Yanming Zhang, Shengli Xue

Review Article

Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects

Bushra Ghafoor, Shameera Shaik Masthan, Maha Hameed, Hafiza Huda Akhtar, Azeem Khalid, Sana Ghafoor, Hassan min Allah, Mohammad Mohsin Arshad, Iman Iqbal, Ahmad Iftikhar, Muhammad Husnain, Faiz Anwer

Original Article

A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia

Liyan Yang, Haiyue Niu, Tian Zhang, Qiuying Cao, Mengyuan Liu, Yumei Liu, Li Yan, Weiwei Qi, Ting Wang, Chunyan Liu, Lijuan Li, Limin Xing, Huaquan Wang, Zonghong Shao, Rong Fu

Original Article

Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia

Antonella Meloni, Laura Pistoia, Paolo Ricchi, Sergio Bagnato, Filomena Longo, Giuseppe Messina, Sabrina Bagnato, Vincenza Rossi, Stefania Renne, Riccardo Righi, Priscilla Fina, Vincenzo Positano, Filippo Cademartiri

Original Article

Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel

Julie Kanter, Kenneth I. Ataga, Neha Bhasin, Stephanie Guarino, Abdullah Kutlar, Sophie Lanzkron, Deepa Manwani, Patrick McGann, Sean R. Stowell, Venée N. Tubman, Irina Yermilov, Cynthia Campos, Michael S. Broder

Original Article

Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia

Daniel Zechariah Paul Jebanesan, Raveen Stephen Stallon Illangeswaran, Bharathi M. Rajamani, Rakhi Thalayattu Vidhyadharan, Saswati Das, Nayanthara K. Bijukumar, Balaji Balakrishnan, Vikram Mathews, Shaji R. Velayudhan, Poonkuzhali Balasubramanian

Open Access Research

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study

F. Palandri, G. Auteri, E. Abruzzese, G. Caocci, M. Bonifacio, F. Mendicino, R. Latagliata, A. Iurlo, F. Branzanti, B. Garibaldi, M. M. Trawinska, D. Cattaneo, M. Krampera, O. Mulas, E. A. Martino, M. Cavo, N. Vianelli, S. Impera, F. Efficace, F. Heidel, M. Breccia, E. M. Elli, G. A. Palumbo

Open Access Research

Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML

Akriti G Jain, Quinto Gesiotto, Somedeb Ball, Lisa Nodzon, Amanda Rodriguez, Onyee Chan, Eric Padron, Andrew Kuykendall, Rami Komrokji, David A. Sallman, Jeffrey E Lancet, Javier Pinilla-Ibarz, Kendra Sweet

Open Access Research

Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis

Chih-Cheng Chen, Justin L. Chen, Alex Jia-Hong Lin, Lennex Hsueh-Lin Yu, Hsin-An Hou

Original Article

1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study

Shuang Gao, Fei Dong, Ping Yang, Yingtong Chen, Yanfang Wang, Jing Wang, Yanyan Shi, Hongmei Jing

Open Access Original Article

Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab

Min Qing, Tianyuan Zhou, Tatiana Perova, Yann Abraham, Cheryl Sweeney, Maria Krevvata, Xiaokang Zhang, Ming Qi, Grace Gao, Tae Min Kim, Ming Yao, Seok-Goo Cho, Hyeon Seok Eom, Soon Thye Lim, Su-peng Yeh, Yok Lam Kwong, Dok Hyun Yoon, Jin Seok Kim, Won Seog Kim, Longen Zhou, Ricardo Attar, Raluca I. Verona

Original Article

Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study

Wenqi Li, Yu Chang, Xiyang Liu, Ziqi Chen, Jinmiao Sun, Zurui Geng, Mingzhi Zhang, Lei Zhang

Open Access Original Article

Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study

Ingo Schwaner, Thomas Kuhn, Christoph Losem, Thomas Wolff, Burkhard Otremba, Matthias Zaiss, Johannes Hülsenbeck, Kirsten Famulla, Thomas Nösslinger, Davide Rossi

Open Access Original Article

Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601

Kazuyuki Shimada, Ken Ohmachi, Ryunosuke Machida, Shuichi Ota, Hidekazu Itamura, Hideki Tsujimura, Nobuyuki Takayama, Takaki Shimada, Mitsutoshi Kurosawa, Takayuki Tabayashi, Tatsu Shimoyama, Koichi Ohshima, Kana Miyazaki, Dai Maruyama, Tomohiro Kinoshita, Kiyoshi Ando, Tomomitsu Hotta, Kunihiro Tsukasaki, Hirokazu Nagai

Original Article

Patterns and prognostic impact of CNS infiltration in adults with newly diagnosed acute lymphoblastic leukemia

Luiza Lapolla Perruso, Elvira Velloso, Vanderson Rocha, Eduardo Magalhaes Rego, Wellington Fernandes Silva

Original Article

Nomogram for predicting survival of patients with diffuse large B-cell lymphoma

Keiichiro Fujii, Atsushi Inagaki, Ayako Masaki, Mariko Sugiura, Tomotaka Suzuki, Takashi Ishida, Shigeru Kusumoto, Shinsuke Iida, Hiroshi Inagaki

Open Access Original Article

Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients

Bo Kyung Kim, Kyung Taek Hong, Jung Yoon Choi, Hyery Kim, Hyun Jin Park, Hyoung Jin Kang

Original Article

Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia

Kumiyo Tazoe, Naonori Harada, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Hiroshi Okamura, Asao Hirose, Mika Nakamae, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae

Research

Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China

Lan Luo, Yang Jiao, Yan Li, Ping Yang, Jinjie Gao, Sai Huang, Wenyang Huang, Jijun Wang, Fei Dong, Xiaoyan Ke, Dehui Zou, Chunji Gao, Hongmei Jing

Research

Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT

Wenwei Shao, Yixuan Wang, Li Liu, Yiran Ren, Jieru Wang, Yuqing Cui, Jia Liu, Xiaoyu Zhang, Sudong Zhang, Shuangjie Liu, Erlie Jiang, Sizhou Feng, Xiaolei Pei

Research

Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series

Mengze Hu, Junhui Li, Rong Liu, Zhaoxia Zhang, Shunqiao Feng, Dixiao Zhong, Ruihong Tang, Litian Xuan

Open Access Original Article

Quality of life after immune suppressive therapy in aplastic anemia

Iris N. Lommerse, Chris Hinnen, Liesbeth M. van Vliet, Beke Schubert, Jens Panse, Constantijn J. M. Halkes, Jennifer M.-L. Tjon

Research

Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies

Patrick Reimann, Verena Petzer, Axel Mündlein, Bernd Hartmann, Luciano Severgnini, Alex Winkler, Theresia Lang, Minh Huynh, Klaus Gasser, Julia Rüger, Michele Atzl, Sylvia Mink, Peter Fraunberger, Stefan Schmidt, Normann Steiner, Andrea Griesmacher, Eberhard Gunsilius, David Nachbaur, Wolfgang Willenbacher, Dominik Wolf, Thomas Winder, Magdalena Anna Benda

Research

Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial

Aishwarya Anand, Naveen C Hegde, Pulkit Chhabra, Jai Purohit, Rupesh Kumar, Ankur Gupta, Deepesh P Lad, Ritin Mohindra, Saurabh Mehrotra, Rajesh Vijayvergiya, Basant Kumar, Vishal Sharma, Pankaj Malhotra, Jasmina Ahluwalia, Reena Das, Amol N Patil, Nusrat Shafiq, Samir Malhotra

Research

Analysis of four hereditary protein C deficiencies associated with vascular thromboembolism

Xuanyu Chen, Chengxiang Yuan, Beilei Hu, Chunxing Lu, Yujia Wang, Zhao Han, Ming Zou

Correspondence

Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis

Marko Lucijanic, Ivan Krecak, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Danijela Lekovic, Rajko Kusec

Correspondence

Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture

Katsuyoshi Shimozawa, Hiroshi Yagasaki, Koji Kanezawa, Ichiro Morioka

Correspondence

Letter to Editor: Treatment with the apoptosis inhibitor asunercept reduces clone sizes in patients with lower risk myelodysplastic neoplasms

Syeda Dua e Zehra Zaidi, Syeda Mahrukh Fatima Zaidi, Burhanuddin Sohail Rangwala

Case Report

Thiotepa-busulfan-fludarabine-based conditioning as a promising approach prior to allogeneic hematopoietic stem cell transplantation in patients with blastic plasmacytoid dendritic cell neoplasm

Xianbo Huang, Shasha Wang, Yu Xu, Chen Mei, Qingmei Han, Xianhui Wu, Fengwei Du, Yanling Ren, Jie Jin, Hongyan Tong, Jiejing Qian

Case Report

Could it be VEXAS?

Hippolyte Guerineau, Milena Kohn, Antoine Al Hamoud, Jacques Sellier, Jennifer Osman, Aurélie Cabannes-Hamy

Case Report

Diagnosing aceruloplasminemia: navigating through red herrings

Zeni Kharel, Himal Kharel, Pradyumna D. Phatak

Letter to the Editor

Systematic analysis of copper, zinc, and selenium levels in JAK2 V617F-positive myeloproliferative neoplasms

Velizar Shivarov, Gergana Tsvetkova, Bisera Atanasova, Mariana P. Genova, Irena Ivanova, Evgueniy Hadjiev, Milena Ivanova

Letter to the Editor

Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia

Hamenth Kumar Palani, Saravanan Ganesan, Nithya Balasundaram, Arvind Venkatraman, Uday Kulkarni, Anu Korula, Sukesh C Nair, Thenmozhi Mani, Poonkuzhali Balasubramanian, Aby Abraham, Vinuth N Puttamallesh, Harsha Gowda, Vikram Mathews

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.